Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV

Funded by the National Institute on Drug Abuse as a Center of Excellence

Learn about us
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College Read more

The Kaiser Commission on Medicaid and the Uninsured recently released an issue brief detailing the most costly outpatient drugs to Medicaid in 2014 and the first half of 2015. Using data from the Center for Medicare and Medicaid Services (CMS), the authors analyzed outpatient drug costs based on Medicaid spending (before rebates) to determine which […]

Read the blog post

In this newsletter, we’d like to share the highlights of our first year including CHERISH joint issue briefs with the Leonard Davis Institute. We also discuss the researchers we’ve had the opportunity to interact with through our methodology consultation service and some of the products that have come from those consultations. We describe the four […]

Read the full story


PA Governor Tom Wolf Urges Medical Professionals to Sign Up   Photo: Hoag Levins Pennsylvania Governor Tom Wolf speaks at a University of Pennsylvania press conference where he announced the launch of a new state prescription drug monitoring system designed to tighten access to prescription opioid drugs and other controlled substances. Pennsylvania Governor Tom Wolf […]

Read the blog post

This Issue Brief discusses the role of primary care teams in identifying illicit drug use disorders in their patients, the continuum of treatments that they can offer, and opportunities for successful collaboration and integration with specialists. The authors find opportunities exist for increased patient screening and delivering medication-assisted treatment as well as established models for […]

Read more


By Hoag Levins 36-Month Study to Focus on Opioid Risk Communications in Clinical Settings University of Pennsylvania Assistant Professor of Emergency Medicine and LDI Senior Fellow Zachary Meisel, MD, has received a $2.1 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). The award will fund a 36-month comparative effectiveness study of enhanced opioid risk […]

Read the full story

Join Our Mailing List


Hepatitis C and HIV in Substance Users: Economics of Screening and Linkage to Care

Wednesday, October 26, 2016
12:00 pm — 1:00 pm
Bruce R. Schackman, PhD, MBA

TreeAge Training

Saturday, December 3, 2016
8:00 am — 6:00 pm


Experts in cost benefit, cost effectiveness, and budget impact analyses

Learn More Consultation Request


Experts in economic analysis of HCV and HIV and treatment among substance users

Learn More Researcher Services

Dissemination and Policy

Experts in disseminating health economic research among policy makers and the public

Learn More

Pilot Grant and Training

Supports new investigators and investigators new to health economic research in substance use disorders, HCV, and HIV

Learn More Pilot Grants

View Our Publications and Presentations